Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
American Oncology Network Inc. (AONC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/16/2025: AONC (3-star) is a STRONG-BUY. BUY since 28 days. Profits (94.47%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
0 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Year Target Price $
Year Target Price $
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 64.6% | Avg. Invested days 30 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 06/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 387.54M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 |
52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.89 |
Earnings Date
Report Date 2025-06-27 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 534565887 | Price to Sales(TTM) 0.22 |
Enterprise Value 534565887 | Price to Sales(TTM) 0.22 | ||
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA 294.53 | Shares Outstanding 29248400 | Shares Floating 8989380 |
Shares Outstanding 29248400 | Shares Floating 8989380 | ||
Percent Insiders 77.99 | Percent Institutions 0.08 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Oncology Network Inc.
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. It focuses on community oncology, aiming to strengthen independent practices through a collaborative network and access to resources and technologies.
Core Business Areas
- Physician Partnerships: AON partners with independent oncology practices, providing them with operational support, technology solutions, and access to a national network.
- Pharmacy Services: AON provides in-house pharmacy services, including oral oncolytics and supportive medications, enhancing patient care and convenience.
- Care Management: AON offers comprehensive care management programs, ensuring patients receive coordinated and personalized care throughout their treatment journey.
- Clinical Trials: AON provides community oncology access to clinical trials and novel treatments to increase the options for patients in their care.
Leadership and Structure
AON's leadership team includes experienced executives in healthcare management, oncology, and pharmacy. The organizational structure emphasizes collaboration and shared resources across its partner practices.
Top Products and Market Share
Key Offerings
- Practice Management Services: Provides comprehensive support to partner oncology practices. Market share data is not publicly available but AON is a major aggregator in the community oncology space. Competitors include McKesson (MCK) and Cardinal Health (CAH).
- Oncology Pharmacy Solutions: Delivers oncology pharmacy services to patients. Market share data is not publicly available, but the market is competitive. Competitors include Walgreens (WBA) and CVS Health (CVS).
- Care Management Programs: Offers comprehensive care management programs for oncology patients. Market share data is not publicly available; these programs provide a key service differentiating AON from purely financial aggregators. Competitors: other vertically integrated healthcare providers.
- Clinical Trials Network: Increases access for community oncologists to cutting edge treatments. Competitors: academic medical centers and pharmaceutical sponsors.
Market Dynamics
Industry Overview
The oncology market is experiencing growth driven by an aging population, advances in treatment, and increased cancer incidence. Community oncology plays a vital role in delivering care to patients in local settings.
Positioning
AON positions itself as a partner and facilitator for independent oncology practices, providing them with scale and resources to compete effectively against hospital systems and larger organizations. Their competitive advantage lies in the integration of services across the care continuum.
Total Addressable Market (TAM)
The TAM for oncology services is substantial, expected to reach hundreds of billions of dollars globally. AON is positioned to capture a portion of this market by serving independent practices and their patients. It is impossible to calculate AON's TAM, given the proprietary nature of the business model.
Upturn SWOT Analysis
Strengths
- Strong network of community oncology practices
- Comprehensive suite of services (practice management, pharmacy, care management)
- Experienced leadership team
- Focus on value-based care
- Access to clinical trials
Weaknesses
- Reliance on physician partnerships
- Profitability not publicly demonstrated
- Dependence on reimbursement rates
- Competition from larger healthcare organizations
Opportunities
- Further expansion of network
- Growth in oncology market
- Increased adoption of value-based care
- Development of new services and technologies
- Potential acquisitions of smaller practices
Threats
- Changes in healthcare regulations
- Reimbursement pressures
- Competition from larger healthcare organizations
- Economic downturn
- Consolidation among payers
Competitors and Market Share
Key Competitors
- McKesson (MCK)
- Cardinal Health (CAH)
- US Oncology Network (part of McKesson)
- OneOncology
Competitive Landscape
AON competes with other oncology networks and healthcare organizations. Its focus on independent practices and integrated services provides a competitive advantage.
Major Acquisitions
Oncology Supply Inc.
- Year: 2021
- Acquisition Price (USD millions): 100
- Strategic Rationale: To expand its pharmaceutical and supply chain capabilities.
Growth Trajectory and Initiatives
Historical Growth: AON has experienced growth in recent years through the addition of new partner practices.
Future Projections: Future growth is expected to be driven by continued expansion of the network and the adoption of new services.
Recent Initiatives: Recent initiatives include the expansion of its pharmacy services and the development of new care management programs.
Summary
American Oncology Network Inc. is a network that supports independent oncology practices by providing them with a variety of services and is experiencing strong growth. As a private company, AON's financials are not public. Consolidation in the oncology space is a key trend, creating both opportunities and threats as the company expands and competes with larger organizations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- American Oncology Network Inc. website
- Industry reports
- News articles
Disclaimers:
Financial data is limited due to the company being privately held. Market share estimates are based on available industry information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc.
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-05 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.